Combo Therapy Shows Promise in Advanced Thymic Epithelial Tumors

(MedPage Today) -- Treatment with avelumab (Bavencio) plus axitinib (Inlyta) showed promising efficacy and safety in patients with unresectable or metastatic type B3 thymoma and thymic carcinoma, according to a single-arm phase II study. Among...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news